Posts

What is the role of CMC in a new drug development process?

CMC, or Chemistry, Manufacturing, and Controls , plays an important role in the new drug development process by ensuring that a drug can be consistently produced with the required quality, safety, strength, purity, and stability. During the phases of pharmaceutical development , CMC activities cover areas such as drug substance development, formulation, manufacturing processes, analytical methods, specifications, packaging, and stability testing. In the early stages of the drug discovery and development process , CMC helps researchers understand the physical and chemical properties of a drug candidate and develop a suitable formulation and manufacturing approach. As the candidate moves into preclinical and clinical development, CMC work becomes more detailed to support reliable production of material for clinical studies. Analytical testing is also used to monitor impurities, identity, potency, purity, and other quality attributes. As development progresses, the manufacturing process ...

What does “phase drug development” mean?

  Phase drug development ” refers to the different stages used to study and evaluate a potential medicine before and after it becomes available to patients. The term is commonly used when discussing the phases of drug development , particularly the clinical phases that test a drug in humans. After discovery and preclinical research, a drug candidate may enter clinical development of drug programs, which are generally divided into Phase I, Phase II, and Phase III studies. Phase I mainly evaluates safety, tolerability, and suitable dosage; Phase II looks more closely at effectiveness and side effects in patients; and Phase III studies the medicine in larger patient groups to confirm its benefits and risks. After successful clinical phases, regulatory authorities review the available evidence before approval, followed by continued safety monitoring after the medicine reaches the market. Therefore, “phase drug development” is essentially a way of describing the structured stages withi...

What are the phases of pharmaceutical development?

  The phases of pharmaceutical development describe the different stages involved in taking a potential medicine from an early idea to an approved product and continued safety monitoring. The process generally begins with drug discovery , where researchers identify and study promising compounds that may help treat a particular disease. This is followed by preclinical development , where laboratory and nonclinical studies are performed to understand the candidate’s safety, pharmacology, toxicity, and other important properties before human testing. The next major stage is clinical development of drug candidates, which includes Phase I, Phase II, and Phase III clinical trials. These studies gradually evaluate safety, dosage, tolerability, effectiveness, and the overall benefit-risk profile in people. After successful clinical studies, the available evidence is submitted for regulatory review and approval . Once the medicine is approved, post-marketing monitoring continues to ident...

What is the difference between drug discovery and drug development?

Drug discovery and drug development are two connected but different stages in bringing a new medicine to patients. Drug discovery is the early part of the drug discovery and development process , where scientists search for potential medicines by studying diseases, biological targets, chemical compounds, and their effects. Researchers identify promising molecules, screen them, and carry out laboratory studies to understand how they may work against a particular disease. The main goal of drug discovery is to find a suitable drug candidate that has the potential to provide a useful therapeutic effect. Drug development starts after a promising candidate has been identified. It involves a much broader and more detailed process to determine whether the candidate can be developed into a safe, effective, and reliable medicine. This can include preclinical studies, formulation development, analytical testing, stability studies, safety assessment, and clinical trials in humans. During the cli...

What are the five main steps of developing a drug?

The new drug development process is a long and carefully planned journey that takes a potential medicine from early research to approval and continued safety monitoring. The main phases of pharmaceutical development include discovery and development, preclinical research, clinical development, regulatory review, and post-market monitoring. During the discovery stage, researchers identify and study promising drug candidates to understand how they may work and select suitable candidates for further development. In preclinical research, the candidate is evaluated through laboratory and nonclinical studies to understand its safety, pharmacology, toxicity, and other important properties before it is tested in humans. The next stage is the clinical development of drug candidates, where clinical trials are conducted in different phases to evaluate safety, dosage, effectiveness, and possible side effects. After enough evidence is collected, the drug is submitted for regulatory review , wher...

Can Molkem investigate pharmaceutical impurities?

  Yes, Molkem can support the investigation of pharmaceutical impurities through its analytical R&D services. Impurity investigation is an important part of pharmaceutical development because unwanted impurities can affect the quality, stability, safety, and performance of a drug substance or finished product. As part of analytical research and development in pharmaceutical industry , impurity studies can support method development, method validation, stability testing, specification setting, quality investigations, and regulatory submissions. These studies help pharmaceutical companies understand impurity profiles and monitor changes during manufacturing and storage. An experienced pharma analytical R&D company like Molkem can provide analytical support to help generate reliable data for pharmaceutical development and quality assessment. Proper impurity investigation helps companies identify potential quality concerns and maintain consistent standards for pharmaceutical ...

When is analytical method validation required?

  Analytical method validation is required when a new analytical method is developed or when an existing method is changed significantly. In the pharmaceutical industry, validation confirms that a method is suitable for its intended purpose and can provide accurate, reliable, and consistent results. It is commonly required for assay testing, impurity testing, stability studies, release testing, and regulatory submissions . As part of analytical research and development in pharmaceutical industry , method validation may also be required when an analytical method is transferred to another laboratory, when there are major changes in the product or manufacturing process, or when the testing procedure is modified. Depending on the method and its purpose, characteristics such as accuracy, precision, specificity, linearity, range, sensitivity, and robustness may be evaluated. A reliable analytical R&D pharma process helps ensure that analytical methods meet their intended requiremen...